BioREtain Early Evaluation Program (BEEP)

If you are interested in learning more about the patented BioREtain process that produces our line of allografts for acute and chronic wounds, please take a minute to fill out the form on this page, and one of our Area Sales Managers will contact you to get started.

VENDAJE is a natural, minimally manipulated structural tissue allograft composed of the amnion layer of the placental membrane.

It is intended for use as a protective covering for soft tissue chronic wounds.

Start your BioREtain Early Evaluation Program

Evaluation Sign Up

Hidden

Next Steps: Sync an Email Add-On

To get the most out of your form, we suggest that you sync this form with an email add-on. To learn more about your email add-on options, visit the following page (https://www.gravityforms.com/the-8-best-email-plugins-for-wordpress-in-2020/). Important: Delete this tip before you publish the form.

About You

Your Name(Required)

First Last

Your Company Address

Street Address Address Line 2 City ZIP Code

Preferred Method of Contact

Area of Practice / Sites of Service:(Required)

Your Email Address(Required)

Email Address Confirm Email Address

Your Phone(Required)

Best Time to Call You(Required)

Your Comments/Questions

See what KOL & Podiatrist with 25 years of experience, Dr. John Starinski has to say about BioREtain tissue processing.

The Difference is in Our Proprietary
BioREtain Process

New studies published in Health Science Reports show our proprietary BioREtain tissue processing producing better results than the market leading allograft company and vs. SOC. Click on the images to access the poster.

A recent study published in Health Science Reports shows that when compared to the leading market allograft:

VENDAJE has proven to be 27% more efficient and reduced treatment days by 14%. This reduces costs, and improves patient outcomes. Click on the picture to the right to read the article.

A retrospective study vs. SOC

The latest VENDAJE AC retrospective vs. SOC shows a nearly 10% higher Expected Wound Closure Rate than SOC, and a 93.6% improvement in Expected Percentage Area Reduction over SOC at 12 weeks! These results can be life-changing for patients with chronic wounds resulting from DFUs.

Our 6-Step Process Preserves the Integrity of the Tissue

Processing Matters!

Our BioREtain method stands apart by adhering to a stringent 6-step process designed to maintain the natural integrity of amniotic tissue. This preservation is crucial for several reasons:

Enhanced Growth Factor Retention: These growth factors are pivotal for promoting cellular migration, proliferation, and differentiation, leading to more efficient tissue repair and regeneration.
Improved Structural Integrity: This structure acts as a scaffold that supports new tissue formation, crucial for effective wound healing.
Reduced Inflammatory Response: Preserving the native properties of the tissue helps minimize the risk of inflammatory responses.

The Science Behind Tissue-Derived Allografts

Biologics in Wound Care

Chronic wounds are wounds that are stuck in the inflammation stage of wound healing. This is especially the case in patients with Diabetic Foot Ulcers.

Biological products, such as those made from human amniotic tissue, are revolutionizing the treatment of DFUs.

Amniotic tissue allografts, like BioStem’s VENDAJE used as a covering for chronic wounds, have proven extremely efficient and can reduce the number of treatment days.

Amniotic tissue provides essential growth factors, anti-inflammatory properties, and a scaffold that encourages tissue regeneration. These allografts help accelerate the body’s own wound healing process by promoting re-epithelialization and tissue remodeling, which are often impaired in diabetic patients.